] > Programma del convegno

Scientific Programme


8.30 - 9.00 am                                   Registration and welcome coffee


Morning session


09.00 - 09.30 am                   Opening remarks and greetings from Institutions*

                                               M Melazzini,

* Have been invited to participate:

Minister of Health, Beatrice Lorenzin

President of the Lombardy Region, Roberto Maroni

Pierfrancesco Majorino - Councillor for Social Policies and health services, City of Milan

09.30 - 10.15 am                   Neuroinflammation Fans the Flames of Neurodegeneration: A Key to Clinical Diversity in ALS

S. H. Appel


Completed AriSLA Funded Projects


10.15 - 10.45 am                   AriSLA Full Grant Project, Call 2010: iPSALS

iPS derived neural stem cells for Amyotrophic Lateral Sclerosis                                

G.P. Comi


10.45 - 11.15 am                   AriSLA Full Grant Project, Call 2010: ALSMNDTDP-43

Molecular characterization of TDP-43 function in vivo and the mechanisms that lead to motoneuron disease in Drosophila models of ALS.

F. Feiguin


11.15 - 11.45 am                   What have animal models taught us about ALS?

W. Robberecht


11.45 - 12.15 pm                   Opportunities and Challenges for using IPS cells in ALS Research

N. J. Maragakis


12.15 - 01.15 pm                   Round Table: novel models for ALS research

                                                  S. H. Appel, L. Bruijn, G.P. Comi, B .G. M. Dickie, F. Feiguin, N. J. Maragakis, P. Pasinelli, G. Pompilio, W. Robberecht


01.15 - 01.30 pm                   Presentation of the "AriSLA Call 2013" winner projects


01.30 - 02.30 pm                   Lunch


01.30 - 03.00 pm                   Poster Session

AriSLA Foundation ongoing Projects (to be evaluated by the Advisory Board members)


Afternoon session


AriSLA Foundation ended projects


03.00 - 03.30 pm                   AriSLA Full Grant Project, Call 2009: PRALS

P2X7 Receptor in Amyotrophic Lateral Sclerosis

N. D'Ambrosi


03.30 - 03.50 pm                   AriSLA Pilot Grant Project, Call 2012: GOALS

Role of autoimmunity in ALS

P. Edomi


03.50 - 04.10 pm                   AriSLA Pilot Grant Project, Call 2012: FUSinteractor

Biochemical and genetic analysis of the interaction between FUS and NonA

G. Cestra


04.10 - 04.30pm                    AriSLA Pilot Grant Project, Call 2011: ALS-MAI

                                               ALS: the role of Microglia, Astrocytes and Inflammation

L. Muzio


04.30 - 04.50 pm                   AriSLA Pilot Grant Project, Call 2011: EcypALS

Extracellular cyclophilin A as a possible therapeutic target for amyotrophic lateral sclerosis                                  

V. Bonetto


04.50 - 05.10 pm                   AriSLA Pilot Grant Project, Call 2012: ALSsiMO

Antisense oligomer against SOD1 for the development of ALS therapy

M. Nizzardo


05.10 - 05.30 pm                   Closing remarks and Best Poster Prize




Stanley H. Appel, Methodist Neurological Institute, Houston, TX, U.S.

Valentina Bonetto, "Mario Negri" Institute for Pharmacological Research, Milan

Gianluca Cestra, IBPM National Research Council (CNR) at "Sapienza University" of Rome

Giacomo Pietro Comi, Department of Pathophysiology Medical Surgical and Transplant, University of Milan

Nadia D'Ambrosi, Institute of Neurobiology and Molecular Medicine, National Research Council (CNR), Rome

Paolo Edomi, Department of Life Sciences, University of Trieste

Fabian Feiguin, International Center for Genetic Engineering and Biotechnology (ICGEB), Trieste

Nicholas  J. Maragakis, The Johns Hopkins Hospital, Baltimore, MD, U.S.

Luca Muzio, San Raffaele Foundation Center, Milan

Monica Nizzardo, Department of Pathophysiology Medical Surgical and Transplant, University of Milan

Wim Robberecht, Vesalius Research Center, Flanders Institute of Biotechnology (VIB), University of Leuven, Belgium




Lucie Bruijn, The ALS Association, Washington DC, U.S.

Brian G.M. Dickie, MND Association, Northampton, UK

Piera Pasinelli, Thomas Jefferson University, PA, U.S.  and Packard Center for ALS Research, Baltimore, MD, U.S.

Giulio Pompilio, AriSLA Foundation, Milan